{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:05:51Z","timestamp":1788303951876,"version":"build-2803163510"},"reference-count":521,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK097253"],"award-info":[{"award-number":["R01DK097253"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK139395"],"award-info":[{"award-number":["R01DK139395"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["HT9425\\u201324\\u20131\\u20130399"],"award-info":[{"award-number":["HT9425\\u201324\\u20131\\u20130399"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.phrs.2026.108104","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:29:44Z","timestamp":1768706984000},"page":"108104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gene modification: Exploring the potential in treating kidney diseases"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-5371","authenticated-orcid":false,"given":"Ubong S.","family":"Ekperikpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6985-821X","authenticated-orcid":false,"given":"Serena","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-5376","authenticated-orcid":false,"given":"Ilse S.","family":"Daehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108104_bib1","doi-asserted-by":"crossref","first-page":"k2179","DOI":"10.1136\/bmj.k2179","article-title":"Role of the gut microbiota in nutrition and health","volume":"361","author":"Valdes","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2026.108104_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2023.05.036","article-title":"How epigenetics impacts on human diseases","volume":"114","author":"Farsetti","year":"2023","journal-title":"Eur. J. Intern. Med."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib4","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.ymthe.2022.04.007","article-title":"Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"issue":"16","key":"10.1016\/j.phrs.2026.108104_bib5","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.3390\/ijms25168592","article-title":"Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease","volume":"25","author":"Gigliotti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri2487","article-title":"Epigenetic control of T-helper-cell differentiation","volume":"9","author":"Wilson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbagen.2008.12.003","article-title":"At the crossroads of T helper lineage commitment\u2014Epigenetics points the way","volume":"1790","author":"Janson","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"issue":"Spec 1","key":"10.1016\/j.phrs.2026.108104_bib8","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1093\/hmg\/ddi115","article-title":"Epigenetic control in the immune response","volume":"14","author":"Reiner","year":"2005","journal-title":"Hum. Mol. Genet"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nsmb.2084","article-title":"Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition","volume":"18","author":"McDonald","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"16","key":"10.1016\/j.phrs.2026.108104_bib10","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/onc.2011.383","article-title":"Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis","volume":"31","author":"Davalos","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2026.108104_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9175806","article-title":"Epigenetics and oxidative stress in aging","volume":"2017","author":"Guillaumet-Adkins","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00467-021-05352-w","article-title":"The potential of RNA-based therapy for kidney diseases","volume":"38","author":"Bondue","year":"2023","journal-title":"Pedia Nephrol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2026.108104_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2025.107042","article-title":"Supplementation of Akkermansia muciniphila improves diabetic kidney disease by regulating gut microbiome in db\/db mice","volume":"69","author":"Liao","year":"2025","journal-title":"Food Biosci."},{"key":"10.1016\/j.phrs.2026.108104_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1874312901206010130","article-title":"Role of MicroRNAs in Fibrosis","volume":"6","author":"Vettori","year":"2012","journal-title":"Open Rheuma J."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory","volume":"15","author":"Kato","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phrs.2026.108104_bib17","article-title":"Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose","volume":"11","author":"Li","year":"2023","journal-title":"FronTCell Dev. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/dme.12775","article-title":"Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes","volume":"32","author":"Swan","year":"2015","journal-title":"Diabet. Med"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib19","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2337\/db18-0537","article-title":"Epigenetics and Epigenomics: Implications for Diabetes and Obesity","volume":"67","author":"Rosen","year":"2018","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib20","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.ajpath.2011.01.044","article-title":"Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism","volume":"178","author":"Advani","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00125-012-2804-x","article-title":"miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes","volume":"56","author":"Zhong","year":"2013","journal-title":"Diabetologia"},{"issue":"121","key":"10.1016\/j.phrs.2026.108104_bib22","doi-asserted-by":"crossref","first-page":"121ra18","DOI":"10.1126\/scitranslmed.3003205","article-title":"MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways","volume":"4","author":"Chau","year":"2012","journal-title":"Sci. Transl. Med"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib23","article-title":"Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study","volume":"14","author":"Qumsani","year":"2025","journal-title":"Biol. (Basel)"},{"issue":"18","key":"10.1016\/j.phrs.2026.108104_bib24","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1007\/s00253-020-10771-0","article-title":"Engineering the gut microbiota to treat chronic diseases","volume":"104","author":"Dosoky","year":"2020","journal-title":"Appl. Microbiol Biotechnol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In Vivo Target Gene Activation via CRISPR\/Cas9-Mediated Trans-epigenetic Modulation","volume":"171","author":"Liao","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jgg.2024.01.002","article-title":"Genome engineering of the human gut microbiome","volume":"51","author":"Zheng","year":"2024","journal-title":"J. Genet. Genom."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/db24-0483","article-title":"Blood-based epigenetic biomarkers associated with incident chronic kidney disease in individuals with type 2 diabetes","volume":"74","author":"Marchiori","year":"2025","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib28","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1152\/ajprenal.00115.2024","article-title":"Update: the role of epigenetics in the metabolic memory of diabetic complications","volume":"327","author":"Chen","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.phrs.2026.108104_bib29","volume":"2023","author":"CfDCa","year":"2023","journal-title":"Chronic Kidney Dis. U. S."},{"issue":"9370","key":"10.1016\/j.phrs.2026.108104_bib30","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(03)13372-7","article-title":"Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia","volume":"361","author":"Ingrosso","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108104_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105256","article-title":"Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice","volume":"106","author":"Kinashi","year":"2024","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl. (2011)"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib33","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/ndt\/gfn040","article-title":"Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2\u20134 chronic kidney disease","volume":"23","author":"Nanayakkara","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.semnephrol.2018.05.016","article-title":"Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy","volume":"38","author":"Novak","year":"2018","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.phrs.2026.108104_bib35","unstructured":"Diseases NIoDaDaK. Kidney Disease Statistics for the United States."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib36","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.phrs.2026.108104_bib37","article-title":"Chromatin methylation abnormalities in autosomal dominant polycystic kidney disease","volume":"9","author":"Xu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.phrs.2026.108104_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJNRD.S363041","article-title":"Genetic susceptibility to chronic kidney disease: links, risks and management","volume":"16","author":"Sawaf","year":"2023","journal-title":"Int J. Nephrol. Renov. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41467-021-21301-5","article-title":"Renal metabolism and hypertension","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib40","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","article-title":"The glomerular filtration barrier: a structural target for novel kidney therapies","volume":"20","author":"Daehn","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2796.2003.01207.x","article-title":"Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure","volume":"254","author":"Tryggvason","year":"2003","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib42","first-page":"34","article-title":"Renal physiology series: Part 1 of 8. Renal anatomy and overview of nephron function","volume":"19","author":"Chmielewski","year":"1992","journal-title":"Anna J."},{"key":"10.1016\/j.phrs.2026.108104_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111825","article-title":"Genetic basis of nephrogenic diabetes insipidus","volume":"560","author":"Hureaux","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib44","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2215\/CJN.11440919","article-title":"Genetic disorders of the glomerular filtration barrier","volume":"15","author":"Li","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","article-title":"Complexities of the glomerular basement membrane","volume":"17","author":"Naylor","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib46","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int"},{"issue":"9722","key":"10.1016\/j.phrs.2026.108104_bib47","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","article-title":"Genetic kidney diseases","volume":"375","author":"Hildebrandt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108104_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1163001","article-title":"Genetic and epigenetic background of diabetic kidney disease","volume":"14","author":"Sandholm","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MNH.0b013e328350313e","article-title":"Towards understanding the inherited susceptibility for nephropathy in diabetes","volume":"21","author":"Thomas","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jama.285.5.545","article-title":"Gene and Stem Cell Therapies","volume":"285","author":"Kaji","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/gjtm.gjtm_87_21","article-title":"Gene therapy \u2013 Principles and Applications","volume":"7","author":"Pathak","year":"2022","journal-title":"Glob. J. Transfus. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1021130127700","article-title":"Gene silencing-based disease resistance","volume":"11","author":"Wassenegger","year":"2002","journal-title":"Transgenic Res"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41434-020-00197-8","article-title":"Gene therapy and gene correction: targets, progress, and challenges for treating human diseases","volume":"29","author":"Cring","year":"2022","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib54","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1016\/j.ymthe.2023.11.001","article-title":"The state of cell and gene therapy in 2023","volume":"31","author":"Chancellor","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108104_bib55","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.944204","article-title":"Editorial: First Regulatory Approvals for CRISPR-Cas9 therapeutic gene editing for sickle cell disease and transfusion-dependent \u03b2-thalassemia","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci. Monit."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccell.2015.03.007","article-title":"The journey from discoveries in fundamental immunology to cancer immunotherapy","volume":"27","author":"Miller","year":"2015","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"3rd. ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib59","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023754","article-title":"Genome-Editing Technologies: Principles and Applications","volume":"8","author":"Gaj","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12934-020-01431-z","article-title":"Application of different types of CRISPR\/Cas-based systems in bacteria","volume":"19","author":"Liu","year":"2020","journal-title":"Micro Cell Fact."},{"issue":"15","key":"10.1016\/j.phrs.2026.108104_bib61","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1093\/nar\/gkt520","article-title":"Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system","volume":"41","author":"Bikard","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"7320","key":"10.1016\/j.phrs.2026.108104_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jgg.2016.01.001","article-title":"Recent Progress in CRISPR\/Cas9 Technology","volume":"43","author":"Mei","year":"2016","journal-title":"J. Genet Genom."},{"issue":"6176","key":"10.1016\/j.phrs.2026.108104_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.phrs.2026.108104_bib65","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"7519","key":"10.1016\/j.phrs.2026.108104_bib66","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature13579","article-title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease","volume":"513","author":"Anders","year":"2014","journal-title":"Nature"},{"issue":"7490","key":"10.1016\/j.phrs.2026.108104_bib67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"issue":"6096","key":"10.1016\/j.phrs.2026.108104_bib68","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2026.108104_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"eLife"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib71","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105779","article-title":"Optimization of Genome Engineering Approaches with the CRISPR\/Cas9 System","volume":"9","author":"Li","year":"2014","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib73","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib74","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf246","article-title":"CRISPR and gene editing for kidney diseases: where are we?","volume":"18","author":"D'Ambrosio","year":"2025","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/acschembio.7b00710","article-title":"Editing the Genome Without Double-Stranded DNA Breaks","volume":"13","author":"Komor","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"6366","key":"10.1016\/j.phrs.2026.108104_bib77","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108104_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15464","article-title":"CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib80","article-title":"Large genomic fragment deletions and insertions in mouse using CRISPR\/Cas9","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"7681","key":"10.1016\/j.phrs.2026.108104_bib81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib82","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","article-title":"Base editing: advances and therapeutic opportunities","volume":"19","author":"Porto","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7603","key":"10.1016\/j.phrs.2026.108104_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108104_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.618406","article-title":"Base and Prime Editing Technologies for Blood Disorders","volume":"3","author":"Antoniou","year":"2021","journal-title":"Front Genome Ed."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s44307-024-00026-8","article-title":"Adenine base editor corrected ADPKD point mutations in hiPSCs and kidney organoids","volume":"2","author":"Wang","year":"2024","journal-title":"Adv. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.kint.2023.11.029","article-title":"In vivo base editing rescues primary hyperoxaluria type 1 in rats","volume":"105","author":"Chen","year":"2024","journal-title":"Kidney Int."},{"issue":"22","key":"10.1016\/j.phrs.2026.108104_bib87","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2026.108104_bib88","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-0716-2501-9_9","article-title":"Chemical modifications of ribosomal RNA","volume":"2533","author":"Sharma","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib89","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0092-8674(95)90003-9","article-title":"Sense from nonsense: RNA editing in mitochondria of kinetoplastid protozoa and slime molds","volume":"81","author":"Simpson","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108104_bib90","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-genom-090413-025405","article-title":"The pivotal regulatory landscape of RNA modifications","volume":"15","author":"Li","year":"2014","journal-title":"Annu Rev. Genom. Hum. Genet"},{"issue":"D1","key":"10.1016\/j.phrs.2026.108104_bib91","doi-asserted-by":"crossref","first-page":"D259","DOI":"10.1093\/nar\/gkv1036","article-title":"RMBase: a resource for decoding the landscape of RNA modifications from high-throughput sequencing data","volume":"44","author":"Sun","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"8001","key":"10.1016\/j.phrs.2026.108104_bib92","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/d41586-024-00275-6","article-title":"Move over, CRISPR: RNA-editing therapies pick up steam","volume":"626","author":"Lenharo","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib93","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ymthe.2023.01.005","article-title":"RNA editing: Expanding the potential of RNA therapeutics","volume":"31","author":"Booth","year":"2023","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib94","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib95","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib96","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the end game: DNA double-strand break repair pathway choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib98","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"7687","key":"10.1016\/j.phrs.2026.108104_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature25164","article-title":"Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents","volume":"553","author":"Gao","year":"2018","journal-title":"Nature"},{"issue":"7785","key":"10.1016\/j.phrs.2026.108104_bib100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib101","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2015-09-618587","article-title":"Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease","volume":"127","author":"Hoban","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib102","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibtech.2023.03.004","article-title":"Prime editing: advances and therapeutic applications","volume":"41","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib103","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib104","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae119","article-title":"Genome editing and kidney health","volume":"17","author":"Tavakolidakhrabadi","year":"2024","journal-title":"Clin. Kidney J."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.gt.3301983","article-title":"Progress and prospects: naked DNA gene transfer and therapy","volume":"10","author":"Herweijer","year":"2003","journal-title":"Gene Ther."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib106","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.biomaterials.2011.01.006","article-title":"A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy","volume":"32","author":"Mao","year":"2011","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib107","first-page":"687","article-title":"Applications and developments of gene therapy drug delivery systems for genetic diseases","volume":"16","author":"Pan","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1566523214666140302193709","article-title":"Basic biology of adeno-associated virus (AAV) vectors used in gene therapy","volume":"14","author":"Balakrishnan","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.phrs.2026.108104_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.753467","article-title":"Adeno-Associated Viruses (AAV) and Host Immunity \u2013 A Race Between the Hare and the Hedgehog","volume":"12","author":"Rapti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108104_bib110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"13","key":"10.1016\/j.phrs.2026.108104_bib111","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2011-09-382317","article-title":"Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer","volume":"119","author":"Buchlis","year":"2012","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.phrs.2026.108104_bib112","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib113","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib114","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa1908490","article-title":"Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A","volume":"382","author":"Pasi","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/mt.2009.258","article-title":"Characterization of genome integrity for oversized recombinant AAV vector","volume":"18","author":"Dong","year":"2010","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib116","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.phrs.2026.108104_bib117","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-7-17","article-title":"Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons","volume":"7","author":"Choi","year":"2014","journal-title":"Mol. Brain"},{"issue":"7546","key":"10.1016\/j.phrs.2026.108104_bib118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108104_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-9139-6_2","article-title":"Design of AAV Vectors for Delivery of Large or Multiple Transgenes","volume":"1950","author":"Patel","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib120","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.phrs.2026.108104_bib121","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1128\/JVI.75.15.6884-6893.2001","article-title":"Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity","volume":"75","author":"Kaludov","year":"2001","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.phrs.2026.108104_bib122","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1128\/JVI.01288-06","article-title":"Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.phrs.2026.108104_bib123","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1128\/JVI.00895-06","article-title":"Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"issue":"40","key":"10.1016\/j.phrs.2026.108104_bib124","doi-asserted-by":"crossref","first-page":"28814","DOI":"10.1074\/jbc.M113.482380","article-title":"Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency","volume":"288","author":"Shen","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib126","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib127","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1006\/mthe.2001.0345","article-title":"Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids","volume":"3","author":"Grifman","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108104_bib128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.omtm.2019.09.003","article-title":"Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors","volume":"15","author":"Eichhoff","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu Rev. Virol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet"},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib131","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41573-023-00762-x","article-title":"Drug delivery systems for CRISPR-based genome editors","volume":"22","author":"Madigan","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"708","key":"10.1016\/j.phrs.2026.108104_bib132","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8226","article-title":"Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome","volume":"15","author":"Ding","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib133","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000000000355","article-title":"Gene Therapy for Glomerular Disease","volume":"35","author":"Saleem","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib134","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2353\/ajpath.2008.070416","article-title":"Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium","volume":"173","author":"Foster","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2026.108104_bib135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.omtm.2020.07.002","article-title":"AAV2\/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction","volume":"18","author":"Yasuda","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16287-z","article-title":"Systemic gene therapy with thymosin \u03b24 alleviates glomerular injury in mice","volume":"12","author":"Mason","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib137","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hgtb.2012.243","article-title":"Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy","volume":"24","author":"Louis Jeune","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib138","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nbt0617-491","article-title":"After Glybera's withdrawal, what's next for gene therapy?","volume":"35","author":"Senior","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"Pt 1","key":"10.1016\/j.phrs.2026.108104_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0022-2836(79)90294-8","article-title":"The nucleotide sequences at the termini of adenovirus-2 DNA","volume":"128","author":"Arrand","year":"1979","journal-title":"J. Mol. Biol."},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108104_bib141","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-1119(80)90169-9","article-title":"The nucleotide sequence of the right-hand terminal SmaI-K fragment of adenovirus type 2 DNA","volume":"9","author":"Shinagawa","year":"1980","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib142","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-Mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib143","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"issue":"9653","key":"10.1016\/j.phrs.2026.108104_bib144","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108104_bib145","series-title":"Adenoviruses","article-title":"Adenoviral Vector-Based Vaccines and Gene Therapies: Current Status and Future Prospects","author":"Shakti","year":"2018"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib146","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.phrs.2026.108104_bib147","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1073\/pnas.91.13.6196","article-title":"Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver","volume":"91","author":"Engelhardt","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib148","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1128\/jvi.70.6.4173-4178.1996","article-title":"Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy","volume":"70","author":"Gorziglia","year":"1996","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib149","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JVI.72.3.2022-2032.1998","article-title":"In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1\/E2A, or E1\/E4 deleted","volume":"72","author":"Lusky","year":"1998","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/cgt.2009.17","article-title":"Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity","volume":"16","author":"Osada","year":"2009","journal-title":"Cancer Gene Ther."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib151","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108104_bib152","article-title":"FDA Approval Summary: Nadofaragene firadenovec-vncg for bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle invasive bladder cancer","author":"Colbert","year":"2024","journal-title":"Clin. Cancer Res"},{"issue":"1, ement 1","key":"10.1016\/j.phrs.2026.108104_bib153","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1046\/j.1523-1755.2002.0610s1120.x","article-title":"Aquaporin gene delivery to kidney","volume":"61","author":"Verkman","year":"2002","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib154","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.gt.3302177","article-title":"Transient foamy virus vector production by adenovirus vectors","volume":"11","author":"Russell","year":"2004","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/v15122378","article-title":"Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines","volume":"15","author":"Trivedi","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib156","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/v16071094","article-title":"Clinical Application of Adenovirus (AdV): A Comprehensive Review","volume":"16","author":"Salauddin","year":"2024","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib157","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1128\/jvi.71.6.4425-4435.1997","article-title":"In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles","volume":"71","author":"Campbell","year":"1997","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/v13081526","article-title":"Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib159","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/mthe.2001.0469","article-title":"Multigene lentiviral vectors based on differential splicing and translational control","volume":"4","author":"Zhu","year":"2001","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1525-0016(03)00104-7","article-title":"Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells","volume":"7","author":"Yu","year":"2003","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib161","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12977-016-0275-8","article-title":"Innate immune defects in HIV permissive cell lines","volume":"13","author":"Rausell","year":"2016","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib162","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/71673","article-title":"Efficient lentiviral transduction of liver requires cell cycling in vivo","volume":"24","author":"Park","year":"2000","journal-title":"Nat. Genet"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib163","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/j.1460-2075.1990.tb08274.x","article-title":"HIV-1 replication is controlled at the level of T-cell activation and proviral integration","volume":"9","author":"Stevenson","year":"1990","journal-title":"Embo J."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib164","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib166","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/mthe.2001.0450","article-title":"Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo","volume":"4","author":"Park","year":"2001","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib167","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/JVI.72.5.3720-3728.1998","article-title":"Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T-cells","volume":"72","author":"Agarwal","year":"1998","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib168","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J. Virol."},{"issue":"10-12","key":"10.1016\/j.phrs.2026.108104_bib169","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jgm.2837","article-title":"Regulated expression of murine CD40L by a lentiviral vector transcriptionally targeted through its endogenous promoter","volume":"17","author":"Fern\u00e1ndez-Rubio","year":"2015","journal-title":"J. Gene Med"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib170","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1182\/blood-2002-02-0578","article-title":"Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene","volume":"101","author":"Marodon","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib171","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/mthe.2002.0542","article-title":"Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors","volume":"5","author":"Vigna","year":"2002","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib172","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nm1398","article-title":"Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer","volume":"12","author":"Brown","year":"2006","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib173","article-title":"Elivaldogene autotemcel approved for treatment of;cerebral adrenoleukodystrophy (CALD) in males: A;therapeutics bulletin of the American College of;Medical Genetics and Genomics (ACMG)","volume":"1","author":"Scott","year":"2023","journal-title":"Genet. Med. Open"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib174","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene Autotemcel Gene Therapy for Non 2013;3b2;x3b2;0 Genotype 3b2;-Thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib175","first-page":"878","article-title":"Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed\/Refractory Large B-Cell Lymphoma","volume":"10","author":"King","year":"2019","journal-title":"J. Adv. Pr. Oncol."},{"key":"10.1016\/j.phrs.2026.108104_bib176","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plasmid.2017.02.001","article-title":"Episomal lentiviral vectors confer erythropoietin expression in dividing cells","volume":"90","author":"Chen","year":"2017","journal-title":"Plasmid"},{"key":"10.1016\/j.phrs.2026.108104_bib177","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.omtm.2018.02.009","article-title":"A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model","volume":"9","author":"Hu","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib178","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/10430340252792530","article-title":"Lentiviral gene transduction of kidney","volume":"13","author":"Gusella","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.phrs.2026.108104_bib179","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.omtm.2022.09.009","article-title":"Lentiviral vector mediated gene therapy for type I Dent disease ameliorates Dent disease-like phenotypes for three months in ClC-5 null mice","volume":"27","author":"Yadav","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/0886022X.2011.559679","article-title":"Biological Effects of Lentivirus-Mediated shRNA Targeting Collagen Type I on the Mesangial Cells of Rats","volume":"33","author":"Zhou","year":"2011","journal-title":"Ren. Fail."},{"key":"10.1016\/j.phrs.2026.108104_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.17","article-title":"Production of lentiviral vectors","volume":"3","author":"Merten","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib182","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000022","article-title":"Quality Control Testing, Characterization and Critical Quality Attributes of Adeno-Associated Virus Vectors Used for Human Gene Therapy","volume":"16","author":"Wright","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.phrs.2026.108104_bib184","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omtm.2019.11.021","article-title":"Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity","volume":"17","author":"Ferreira","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2026.108104_bib185","doi-asserted-by":"crossref","DOI":"10.3390\/v12020137","article-title":"SV40 Large T Antigen Is Not Responsible for the Loss of STING in 293T-cells but Can Inhibit cGAS-STING Interferon Induction","volume":"12","author":"Reus","year":"2020","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib186","first-page":"985","article-title":"Development of tumorigenicity in simian virus 40-immortalized human bronchial epithelial cell lines","volume":"53","author":"Reddel","year":"1993","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib187","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9343(03)00087-1","article-title":"Simian virus 40 in human cancers","volume":"114","author":"Vilchez","year":"2003","journal-title":"Am. J. Med"},{"key":"10.1016\/j.phrs.2026.108104_bib188","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3389\/fimmu.2018.00844","article-title":"Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo","volume":"9","author":"Pei","year":"2018","journal-title":"Front Immunol."},{"issue":"7-8","key":"10.1016\/j.phrs.2026.108104_bib189","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41434-023-00398-x","article-title":"Large-scale purification of functional AAV particles packaging the full genome using short-term ultracentrifugation with a zonal rotor","volume":"30","author":"Wada","year":"2023","journal-title":"Gene Ther."},{"issue":"15-16","key":"10.1016\/j.phrs.2026.108104_bib190","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1089\/hum.2020.054","article-title":"Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing","volume":"32","author":"Selvaraj","year":"2021","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib191","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/hum.2010.241","article-title":"A versatile adeno-associated virus vector producer cell line method for scalable vector production of different serotypes","volume":"22","author":"Yuan","year":"2011","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib192","first-page":"169","article-title":"A clinician's guide to AAV production - How manufacturing platforms shape vector properties","volume":"37","author":"Magnus","year":"2025","journal-title":"Med Genet"},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111051","article-title":"Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges","volume":"12","author":"Mart\u00ednez-Molina","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib194","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3343\/alm.2023.0382","article-title":"Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation","volume":"44","author":"Lee","year":"2024","journal-title":"Ann. Lab Med"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib196","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/hum.2019.143","article-title":"Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome","volume":"30","author":"Aronson","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"46","key":"10.1016\/j.phrs.2026.108104_bib197","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered Nanoparticles for Drug Delivery in Cancer Therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib198","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1872211310666161004155757","article-title":"Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents","volume":"10","author":"Jha","year":"2016","journal-title":"Recent Pat. Drug Deliv. Formul."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib199","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/08982104.2019.1630643","article-title":"Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection","volume":"30","author":"Hattori","year":"2020","journal-title":"J. Liposome Res."},{"issue":"24","key":"10.1016\/j.phrs.2026.108104_bib200","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","article-title":"Nanotech approaches to drug delivery and imaging","volume":"8","author":"Sahoo","year":"2003","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib201","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal Formulations in Clinical Use: An Updated Review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(91)80699-4","article-title":"Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo","volume":"284","author":"Mori","year":"1991","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1248\/bpb.b15-00751","article-title":"Effect of Complexin II on Membrane Fusion between Liposomes Containing MasT-cell SNARE Proteins","volume":"39","author":"Tadokoro","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2026.108104_bib204","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.12.008","article-title":"Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy","volume":"199","author":"Pasut","year":"2015","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib205","first-page":"710","article-title":"Cationic liposome-mediated gene transfer","volume":"2","author":"Gao","year":"1995","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41578-021-00281-4","article-title":"Let\u2019s talk about lipid nanoparticles","volume":"6","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib207","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib208","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1172\/JCI429","article-title":"Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo","volume":"101","author":"Maeshima","year":"1998","journal-title":"J. Clin. Investig."},{"issue":"21","key":"10.1016\/j.phrs.2026.108104_bib209","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1016\/S0021-9258(18)63828-1","article-title":"Introduction and expression of the human insulin gene in adult rat liver","volume":"264","author":"Kaneda","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10157-007-0459-6","article-title":"Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease","volume":"11","author":"Tomita","year":"2007","journal-title":"Clin. Exp. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib211","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.gt.3302696","article-title":"Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction","volume":"13","author":"Chae","year":"2006","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib212","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/21691401.2017.1377725","article-title":"Carbon quantum dots: recent progresses on synthesis, surface modification and applications","volume":"46","author":"Farshbaf","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib213","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/pharmaceutics15051502","article-title":"Cationic Polymers as Transfection Reagents for Nucleic Acid Delivery","volume":"15","author":"Cai","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib214","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1166\/jnn.2012.6372","article-title":"Kidney-specific peptide-conjugated poly(ester amine) for the treatment of kidney fibrosis","volume":"12","author":"Kim","year":"2012","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.phrs.2026.108104_bib215","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in gene therapy: Current status and clinical applications","volume":"362","author":"Casper","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.108104_bib216","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.actbio.2016.11.013","article-title":"Carbon nanotubes as gene carriers: Focus on internalization pathways related to functionalization and properties","volume":"49","author":"Caoduro","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2026.108104_bib217","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.carbon.2018.09.019","article-title":"Graphene-based Nano-Carrier modifications for gene delivery applications","volume":"140","author":"Imani","year":"2018","journal-title":"Carbon"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib218","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.cclet.2017.07.012","article-title":"Advances in quantum dot-mediated siRNA delivery","volume":"28","author":"He","year":"2017","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib219","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1021\/ja310432u","article-title":"An exceptionally simple strategy for DNA-functionalized Up-conversion nanoparticles as biocompatible agents for nanoassembly, DNA delivery, and imaging","volume":"135","author":"Li","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib220","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/anie.200703039","article-title":"Inorganic nanoparticles as carriers of nucleic acids into cells","volume":"47","author":"Sokolova","year":"2008","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.phrs.2026.108104_bib221","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jphotobiol.2013.10.019","article-title":"Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer","volume":"130","author":"Heidari","year":"2014","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib222","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.3390\/ijms15058216","article-title":"Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan","volume":"15","author":"Madhusudhan","year":"2014","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib223","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/21691401.2017.1305393","article-title":"Gold nanoparticles applications: from artificial enzyme till drug delivery","volume":"46","author":"Golchin","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib224","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1208\/s12248-015-9780-2","article-title":"A Review of Clinical Translation of Inorganic Nanoparticles","volume":"17","author":"Anselmo","year":"2015","journal-title":"Aaps J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v13010060","article-title":"A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient","volume":"13","author":"Lebeaux","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib226","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1159\/000486117","article-title":"Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii","volume":"44","author":"Yin","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt940","article-title":"Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase","volume":"22","author":"Kim","year":"2004","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib228","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.76.3.200","article-title":"The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation","volume":"76","author":"Jerne","year":"1956","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.108104_bib229","article-title":"Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro","volume":"7","author":"Khan Mirzaei","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/14787210.2015.990383","article-title":"Phage approved in food, why not as a therapeutic?","volume":"13","author":"Sarhan","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib231","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib232","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/17425247.2014.927437","article-title":"Bacteriophages as vehicles for gene delivery into mammalian cells: prospects and problems","volume":"11","author":"Bakhshinejad","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.phrs.2026.108104_bib233","series-title":"Gene Therapy of Cancer: Methods and Protocols","first-page":"87","article-title":"Use of Minicircle Plasmids for Gene Therapy","author":"Mayrhofer","year":"2009"},{"key":"10.1016\/j.phrs.2026.108104_bib234","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.omtn.2023.04.003","article-title":"Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors","volume":"32","author":"Williams","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib235","doi-asserted-by":"crossref","DOI":"10.3390\/genes8020065","article-title":"Advances in Non-Viral DNA Vectors for Gene Therapy","volume":"8","author":"Hardee","year":"2017","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102682","article-title":"Progress and prospect of minicircle as a minimized non-viral DNA vector in gene therapy and regenerative medicine","volume":"36","author":"Chanani","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2026.108104_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106107","article-title":"Suicide nanoplasmids coding for ribosome-inactivating proteins","volume":"170","author":"Mitdank","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2026.108104_bib238","series-title":"Novel Gene Therapy Approaches","article-title":"Targeted Gene Delivery: Importance of Administration Routes","author":"Shintaro","year":"2013"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib239","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/eji.1830270312","article-title":"Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts","volume":"27","author":"Gah\u00e9ry-S\u00e9gard","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"20","key":"10.1016\/j.phrs.2026.108104_bib240","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1128\/JVI.00512-06","article-title":"Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway","volume":"80","author":"Leopold","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.phrs.2026.108104_bib241","series-title":"Drug Delivery to the Central Nervous System","first-page":"137","article-title":"Intrathecal Drug Delivery by Implanted Pumps","author":"Belverud","year":"2010"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib242","first-page":"27","article-title":"Intrathecal drug delivery systems","volume":"14","author":"Lynch","year":"2013","journal-title":"Contin. Educ. Anaesth. Crit. Care Pain."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib243","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/ijms20123108","article-title":"Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis","volume":"20","author":"Abdul Razzak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib244","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molmed.2021.09.007","article-title":"Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders","volume":"28","author":"Marchi","year":"2022","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.phrs.2026.108104_bib245","series-title":"Drug Delivery to the Central Nervous System","first-page":"85","article-title":"Intraparenchymal Delivery and Its Discontents","author":"Raghavan","year":"2010"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib246","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40263-022-00941-1","article-title":"Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy","volume":"36","author":"Blair","year":"2022","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib247","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa2307952","article-title":"Intrathecal Gene Therapy for Giant Axonal Neuropathy","volume":"390","author":"Bharucha-Goebel","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib248","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib249","article-title":"P014: First-in-human phase 1\/2 trial of intravenous FBX-101 with cord blood transplantation increases GALC, brain and motor development in infantile Krabbe","volume":"1","author":"Escolar","year":"2023","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.phrs.2026.108104_bib250","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.2147\/OPTH.S231804","article-title":"Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence","volume":"14","author":"Gao","year":"2020","journal-title":"Clin. Ophthalmol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib251","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1089\/hum.2019.127","article-title":"Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections","volume":"30","author":"Rubin","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib252","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib253","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/jvi.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors","volume":"71","author":"Lieber","year":"1997","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib254","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1681\/ASN.2018040426","article-title":"Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector","volume":"29","author":"Ikeda","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib255","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54475-9","article-title":"Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids","volume":"15","author":"Furusho","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib256","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1523-1755.2004.05409.x","article-title":"Gene therapy in renal diseases","volume":"65","author":"Imai","year":"2004","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib257","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41436-021-01127-8","article-title":"The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation","volume":"23","author":"Schrezenmeier","year":"2021","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib258","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","article-title":"Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"101","author":"K\u00f6ttgen","year":"2022","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib259","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MNH.0000000000000486","article-title":"Diagnosis of monogenic chronic kidney diseases","volume":"28","author":"Armstrong","year":"2019","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00019053-200725030-00003","article-title":"Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson disease","volume":"25","author":"Moore","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"18","key":"10.1016\/j.phrs.2026.108104_bib261","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","article-title":"Treatment of lysosomal storage disorders: progress with enzyme replacement therapy","volume":"67","author":"Rohrbach","year":"2007","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib262","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1440-1754.2007.01077.x","article-title":"Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: Results of a three-year national surveillance study","volume":"43","author":"Wong","year":"2007","journal-title":"J. Paediatr. Child Health"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib263","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","volume":"91","author":"Bierzynska","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib264","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib265","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","article-title":"Molecular stratification of idiopathic nephrotic syndrome","volume":"15","author":"Saleem","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib266","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.krcp.2012.04.323","article-title":"Current concepts of the podocyte in nephrotic syndrome","volume":"31","author":"Ding","year":"2012","journal-title":"Kidney Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib267","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","article-title":"Positionally Cloned Gene for a Novel Glomerular Protein\u2014Nephrin\u2014Is Mutated in Congenital Nephrotic Syndrome","volume":"1","author":"Kestil\u00e4","year":"1998","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib268","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2353\/ajpath.2010.080843","article-title":"Inducible nephrin transgene expression in podocytes rescues nephrin-deficient mice from perinatal death","volume":"176","author":"Juhila","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib269","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/humu.22485","article-title":"NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum","volume":"35","author":"Bouchireb","year":"2014","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1600-0854.2003.00148.x","article-title":"Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations","volume":"5","author":"Roselli","year":"2004","journal-title":"Traffic"},{"issue":"17","key":"10.1016\/j.phrs.2026.108104_bib271","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174722","article-title":"Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice","volume":"134","author":"Wu","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib272","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1681\/ASN.2013070798","article-title":"Feasibility of repairing glomerular basement membrane defects in Alport syndrome","volume":"25","author":"Lin","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib273","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ng.377","article-title":"Multiple loci associated with indices of renal function and chronic kidney disease","volume":"41","author":"Kottgen","year":"2009","journal-title":"Nat. Genet"},{"issue":"21","key":"10.1016\/j.phrs.2026.108104_bib274","first-page":"2080","article-title":"Diagnostic Utility of Exome Sequencing for Kidney Disease. Reply","volume":"380","author":"Groopman","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib275","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41431-019-0537-8","article-title":"New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells","volume":"28","author":"Daga","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib276","article-title":"Creation of X-linked Alport syndrome rat model with Col4a5 deficiency","volume":"11","author":"Namba","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib277","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41581-023-00702-3","article-title":"Cell and gene therapy for kidney disease","volume":"19","author":"Peek","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib278","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib279","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s12276-021-00683-y","article-title":"Human kidney organoids reveal the role of glutathione in Fabry disease","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108104_bib280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trsl.2023.02.005","article-title":"CRISPR\/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model","volume":"258","author":"Cui","year":"2023","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib281","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrneph.2014.216","article-title":"Causes and pathogenesis of focal segmental glomerulosclerosis","volume":"11","author":"Fogo","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib282","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib283","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.kint.2016.06.032","article-title":"Loss of endogenous thymosin \u03b2(4) accelerates glomerular disease","volume":"90","author":"Vasilopoulou","year":"2016","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib284","doi-asserted-by":"crossref","first-page":"F1026","DOI":"10.1152\/ajprenal.00562.2015","article-title":"The anti-inflammatory peptide Ac-SDKP is released from thymosin-\u03b24 by renal meprin-\u03b1 and prolyl oligopeptidase","volume":"310","author":"Kumar","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib285","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202000029","article-title":"Peptides in Plasma, Urine, and Dialysate: Toward Unravelling Renal Peptide Handling","volume":"15","author":"He","year":"2021","journal-title":"Proteom. Clin. Appl."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib286","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 Nephropathy: From Genetics to Clinical Applications","volume":"16","author":"Friedman","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5993","key":"10.1016\/j.phrs.2026.108104_bib287","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib288","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib289","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.coi.2009.05.024","article-title":"Human innate immunity against African trypanosomes","volume":"21","author":"Pays","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib290","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfy073","article-title":"G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa","volume":"12","author":"Sumaili","year":"2018","journal-title":"Clin. Kidney J."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib291","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib292","article-title":"A Case of COVID-Associated Nephropathy (COVAN)","volume":"14","author":"Craig","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib293","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41581-020-0332-3","article-title":"COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19","volume":"16","author":"Velez","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib294","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.0000000000000219","article-title":"Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease","volume":"34","author":"Hung","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"issue":"26","key":"10.1016\/j.phrs.2026.108104_bib295","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1056\/NEJMoa063265","article-title":"Human Trypanosoma evansi Infection Linked to a Lack of Apolipoprotein L-I","volume":"355","author":"Vanhollebeke","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib296","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-\u03b3\u2013induced proteinuria in APOL1-transgenic mice","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib297","doi-asserted-by":"crossref","first-page":"203","DOI":"10.34067\/KID.0000422019","article-title":"Profiling APOL1 Nephropathy Risk Variants in Genome-Edited Kidney Organoids with Single-Cell Transcriptomics","volume":"1","author":"Liu","year":"2020","journal-title":"Kidney360"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib298","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.34067\/KID.0004522021","article-title":"Autosomal Dominant Polycystic Kidney Disease Prevalence among a Racially Diverse United States Population, 2002 through 2018","volume":"2","author":"Aung","year":"2021","journal-title":"Kidney360"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib299","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"9569","key":"10.1016\/j.phrs.2026.108104_bib300","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib301","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166348","article-title":"The genetics of Autosomal Recessive Polycystic Kidney Disease (ARPKD)","volume":"1868","author":"Goggolidou","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2026.108104_bib302","first-page":"389","article-title":"Acquired Cystic Kidney Disease","volume":"43","author":"Chang","year":"2023"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib303","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","article-title":"Estimating prevalence in single-gene kidney diseases progressing to renal failure","volume":"58","author":"Levy","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.phrs.2026.108104_bib304","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fped.2017.00279","article-title":"The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians","volume":"5","author":"Cordido","year":"2017","journal-title":"Front Pedia"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib305","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1038\/ncomms9715","article-title":"Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids","volume":"6","author":"Freedman","year":"2015","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib306","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41588-021-00946-4","article-title":"Renal plasticity revealed through reversal of polycystic kidney disease in mice","volume":"53","author":"Dong","year":"2021","journal-title":"Nat. Genet"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib307","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.stem.2024.03.005","article-title":"Genetics of cystogenesis in base-edited human organoids reveal therapeutic strategies for polycystic kidney disease","volume":"31","author":"Vishy","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib308","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2543","article-title":"Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing","volume":"45","author":"Kirby","year":"2013","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib309","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1038\/s41598-020-65491-2","article-title":"SMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.phrs.2026.108104_bib310","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/hmg\/ddq205","article-title":"A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure","volume":"19","author":"Bernascone","year":"2010","journal-title":"Hum. Mol. Genet"},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib311","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1600-0854.2006.00481.x","article-title":"Defective intracellular trafficking of uromodulin mutant isoforms","volume":"7","author":"Bernascone","year":"2006","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib312","doi-asserted-by":"crossref","first-page":"F559","DOI":"10.1152\/ajprenal.00143.2004","article-title":"Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice","volume":"288","author":"Bachmann","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"34","key":"10.1016\/j.phrs.2026.108104_bib313","doi-asserted-by":"crossref","first-page":"30200","DOI":"10.1074\/jbc.M111.222968","article-title":"Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner","volume":"286","author":"Mutig","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.phrs.2026.108104_bib314","article-title":"Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients","volume":"98","author":"Steubl","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib315","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2011.134","article-title":"The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease","volume":"80","author":"Rampoldi","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib316","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48014-6","article-title":"Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein","volume":"9","author":"Schaeffer","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib317","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.ekir.2020.09.042","article-title":"Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease","volume":"5","author":"Izzi","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib318","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajhg.2016.05.028","article-title":"Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia","volume":"99","author":"Bolar","year":"2016","journal-title":"Am. J. Hum. Genet"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib319","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.ackd.2016.11.012","article-title":"Autosomal Dominant Tubulointerstitial Kidney Disease","volume":"24","author":"Bleyer","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib320","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1038\/s41467-023-42154-0","article-title":"MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice","volume":"14","author":"Kim","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib321","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00240-018-1101-7","article-title":"Cystinuria: genetic aspects, mouse models, and a new approach to therapy","volume":"47","author":"Sahota","year":"2019","journal-title":"Urolithiasis"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib322","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MNH.0000000000000768","article-title":"Gene therapy for kidney disease: targeting cystinuria","volume":"31","author":"Peek","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib323","first-page":"681","article-title":"Cystinuria: Review of a Life-long and Frustrating Disease","volume":"94","author":"Kowalczyk","year":"2021","journal-title":"Yale J. Biol. Med"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib324","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-7-19","article-title":"Cystinuria: an inborn cause of urolithiasis","volume":"7","author":"Eggermann","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib325","doi-asserted-by":"crossref","DOI":"10.1002\/dvg.23357","article-title":"CRISPR\/Cas9 engineering of albino cystinuria Type A mice","volume":"58","author":"Beckermann","year":"2020","journal-title":"Genesis"},{"issue":"17","key":"10.1016\/j.phrs.2026.108104_bib326","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/ddg189","article-title":"A mouse model for cystinuria type I","volume":"12","author":"Peters","year":"2003","journal-title":"Hum. Mol. Genet"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib327","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137277","article-title":"Digenic Inheritance in Cystinuria Mouse Model","volume":"10","author":"Espino","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib328","doi-asserted-by":"crossref","first-page":"F732","DOI":"10.1152\/ajprenal.00121.2007","article-title":"Slc7a9 knockout mouse is a good cystinuria model for antilithiasic pharmacological studies","volume":"293","author":"Font-Llitj\u00f3s","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib329","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102639","article-title":"Partial correction of cystinuria type A in mice via kidney-targeted transposon delivery","volume":"36","author":"Woodard","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib330","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/15440","article-title":"Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities","volume":"23","author":"Igarashi","year":"1999","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib331","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI107559","article-title":"Enzymatically inactive red cell carbonic anhydrase B in a family with renal tubular acidosis","volume":"53","author":"Shapira","year":"1974","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2026.108104_bib332","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/joneph\/23.S16.S57","article-title":"Familial renal tubular acidosis","volume":"23 16","author":"Alper","year":"2010","journal-title":"J. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib333","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s004390050419","article-title":"Carbonic anhydrase II (CA II) deficiency in Maghrebian patients: evidence for founder effect and genomic recombination at the CA II locus","volume":"99","author":"Fathallah","year":"1997","journal-title":"Hum. Genet"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib334","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1093\/ndt\/gfs493","article-title":"Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies","volume":"27","author":"Haque","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib335","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI1694","article-title":"Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy","volume":"101","author":"Lai","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2026.108104_bib336","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000313962","article-title":"Toward understanding renal Fanconi syndrome: step by step advances through experimental models","volume":"169","author":"Sirac","year":"2011","journal-title":"Contrib. Nephrol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib337","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","article-title":"A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome","volume":"362","author":"Magen","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib338","doi-asserted-by":"crossref","first-page":"267","DOI":"10.23876\/j.krcp.19.056","article-title":"Proximal renal tubular acidosis with and without Fanconi syndrome","volume":"38","author":"Kashoor","year":"2019","journal-title":"Kidney Res Clin. Pr."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib339","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s004670050495","article-title":"The Fanconi syndrome of cystinosis: insights into the pathophysiology","volume":"12","author":"Baum","year":"1998","journal-title":"Pedia Nephrol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMra020552","article-title":"Cystinosis","volume":"347","author":"Gahl","year":"2002","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib341","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1051\/medsci\/2023025","article-title":"Cystinosis: From the gene identification to the first gene therapy clinical trial","volume":"39","author":"Cherqui","year":"2023","journal-title":"Med Sci. (Paris)"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib342","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1167\/iovs.15-17107","article-title":"Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation","volume":"56","author":"Rocca","year":"2015","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib343","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1210\/en.2015-1762","article-title":"Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model","volume":"157","author":"Gaide Chevronnay","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib344","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/ndt\/gfp553","article-title":"Renal phenotype of the cystinosis mouse model is dependent upon genetic background","volume":"25","author":"Nevo","year":"2010","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib345","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020190","article-title":"Nephropathic Cystinosis: Pathogenic Roles of Inflammation and Potential for New Therapies","volume":"11","author":"Elmonem","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib346","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpeds.2009.07.016","article-title":"Twice-daily cysteamine bitartrate therapy for children with cystinosis","volume":"156","author":"Dohil","year":"2010","journal-title":"J. Pedia"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib347","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00860767","article-title":"Approval of cysteamine for patients with cystinosis","volume":"9","author":"Schneider","year":"1995","journal-title":"Pedia Nephrol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib348","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ki.2010.537","article-title":"Kidney preservation by bone marrow cell transplantation in hereditary nephropathy","volume":"79","author":"Yeagy","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib349","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/mt.2012.214","article-title":"Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis","volume":"21","author":"Harrison","year":"2013","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib350","first-page":"473","article-title":"Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance","volume":"87","author":"Wrong","year":"1994","journal-title":"Qjm"},{"issue":"6564","key":"10.1016\/j.phrs.2026.108104_bib351","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/379445a0","article-title":"A common molecular basis for three inherited kidney stone diseases","volume":"379","author":"Lloyd","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib352","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","article-title":"Dent Disease with mutations in OCRL1","volume":"76","author":"Hoopes","year":"2005","journal-title":"Am. J. Hum. Genet"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib353","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/ndt\/gfr475","article-title":"Genetic basis of Bartter syndrome in Korea","volume":"27","author":"Lee","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.phrs.2026.108104_bib354","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJNRD.S155397","article-title":"Bartter syndrome: causes, diagnosis, and treatment","volume":"11","author":"Cunha","year":"2018","journal-title":"Int J. Nephrol. Renov. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib355","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng1096-152","article-title":"Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK","volume":"14","author":"Simon","year":"1996","journal-title":"Nat. Genet"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib356","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1097-171","article-title":"Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III","volume":"17","author":"Simon","year":"1997","journal-title":"Nat. Genet"},{"issue":"13","key":"10.1016\/j.phrs.2026.108104_bib357","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa032843","article-title":"Salt wasting and deafness resulting from mutations in two chloride channels","volume":"350","author":"Schlingmann","year":"2004","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib358","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng752","article-title":"Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure","volume":"29","author":"Birkenh\u00e4ger","year":"2001","journal-title":"Nat. Genet"},{"issue":"19","key":"10.1016\/j.phrs.2026.108104_bib359","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa1507629","article-title":"Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations","volume":"374","author":"Laghmani","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib360","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/01.ASN.0000025781.16723.68","article-title":"Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome","volume":"13","author":"Vargas-Poussou","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib361","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1073\/pnas.090091297","article-title":"Uncompensated polyuria in a mouse model of Bartter's syndrome","volume":"97","author":"Takahashi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib362","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12519-012-0333-9","article-title":"Understanding Bartter syndrome and Gitelman syndrome","volume":"8","author":"Fremont","year":"2012","journal-title":"World J. Pedia"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib363","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24033019","article-title":"CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman's Disease Phenotype in a Patient-Derived Kidney Organoid System","volume":"24","author":"Lim","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108104_bib364","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IBPC.S188869","article-title":"Liddle's syndrome mechanisms, diagnosis and management","volume":"12","author":"Enslow","year":"2019","journal-title":"Integr. Blood Press Control"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9343(98)00018-7","article-title":"Liddle's syndrome","volume":"104","author":"Palmer","year":"1998","journal-title":"Am. J. Med"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib366","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1681\/ASN.V10122527","article-title":"A mouse model for Liddle's syndrome","volume":"10","author":"Pradervand","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2026.108104_bib367","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1016\/S1525-0016(16)40390-4","article-title":"987. Gene Therapy for Nephrogenic Diabetes Insipidus: Renal Medulla Targeted Aquaporin2 Expression by Sendai-Virus Vector Rescued Polyurea in Rat Models","volume":"16","author":"Makoto Inoue","year":"2008","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib368","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40620-023-01804-8","article-title":"Monogenic and polygenic concepts in chronic kidney disease (CKD)","volume":"37","author":"Jefferis","year":"2024","journal-title":"J. Nephrol."},{"key":"10.1016\/j.phrs.2026.108104_bib369","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1380476","article-title":"The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity","volume":"15","author":"Kopczy\u0144ska","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib370","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"46","key":"10.1016\/j.phrs.2026.108104_bib371","doi-asserted-by":"crossref","first-page":"29013","DOI":"10.1073\/pnas.2005905117","article-title":"Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease","volume":"117","author":"Sheng","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib372","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12916-022-02723-4","article-title":"Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis","volume":"21","author":"Jin","year":"2023","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib373","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2004080648","article-title":"Mouse models of diabetic nephropathy","volume":"16","author":"Breyer","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib374","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1681\/ASN.2013070810","article-title":"Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy","volume":"25","author":"Jha","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00125-015-3796-0","article-title":"Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy","volume":"59","author":"Jha","year":"2016","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib376","doi-asserted-by":"crossref","first-page":"F135","DOI":"10.1152\/ajprenal.00047.2023","article-title":"Redox regulation in diabetic kidney disease","volume":"325","author":"Daehn","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib377","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2337\/db16-0695","article-title":"Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility","volume":"66","author":"Qi","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib378","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s42255-023-00776-0","article-title":"Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR","volume":"5","author":"Wang","year":"2023","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib379","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/antiox13060712","article-title":"Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease","volume":"13","author":"Korsmo","year":"2024","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib380","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-021-00415-5","article-title":"Key metalloproteinase-mediated pathways in the kidney","volume":"17","author":"Wozniak","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib381","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000499876","article-title":"Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal","volume":"44","author":"Zakiyanov","year":"2019","journal-title":"Kidney Blood Press. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib382","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V113574","article-title":"Matrix Metalloproteinases in Renal Development and Disease","volume":"11","author":"LENZ","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib383","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/FJC.0000000000001473","article-title":"Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy","volume":"82","author":"Hirata","year":"2023","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108104_bib384","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1627143","article-title":"Matrix Metalloproteinase-9 \u22121562C\/T Gene Polymorphism Is Associated with Diabetic Nephropathy","volume":"2016","author":"Feng","year":"2016","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib385","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0272-6386(03)00416-5","article-title":"Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients","volume":"42","author":"Hirakawa","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib386","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ki.2014.67","article-title":"Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation","volume":"86","author":"Li","year":"2014","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib387","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005168","article-title":"Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians","volume":"4","author":"Ahluwalia","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib388","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.kint.2022.08.026","article-title":"The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease","volume":"102","author":"Fu","year":"2022","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib389","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000478869","article-title":"TNF-\u03b1 Deficiency Prevents Renal Inflammation and Oxidative Stress in Obese Mice","volume":"42","author":"Wang","year":"2017","journal-title":"Kidney Blood Press. Res."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222352","article-title":"CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib391","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12964-024-01565-2","article-title":"Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-\u03baB signaling in diabetic kidney disease","volume":"22","author":"Cui","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib392","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.kint.2022.06.010","article-title":"Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease","volume":"102","author":"Shahzad","year":"2022","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib393","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-008-0961-8","article-title":"What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?","volume":"51","author":"Satchell","year":"2008","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib394","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db18-0045","article-title":"VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy","volume":"68","author":"Onions","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108104_bib395","article-title":"Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes","author":"Martin Alonso","year":"2025","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib396","doi-asserted-by":"crossref","first-page":"F1213","DOI":"10.1152\/ajprenal.00335.2005","article-title":"Identification of a QTL on chromosome 1 for impaired autoregulation of RBF in fawn-hooded hypertensive rats","volume":"290","author":"L\u00f3pez","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib397","doi-asserted-by":"crossref","first-page":"F565","DOI":"10.1152\/ajprenal.00404.2012","article-title":"Genetic basis of the impaired renal myogenic response in FHH rats","volume":"304","author":"Burke","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib398","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.119.258954","article-title":"Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury","volume":"370","author":"Zhang","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib399","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1681\/ASN.2019080784","article-title":"A Mutation in \u03b3-Adducin Impairs Autoregulation of Renal Blood Flow and Promotes the Development of Kidney Disease","volume":"31","author":"Fan","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib400","doi-asserted-by":"crossref","first-page":"F624","DOI":"10.1152\/ajprenal.00239.2020","article-title":"Impaired renal hemodynamics and glomerular hyperfiltration contribute to hypertension-induced renal injury","volume":"319","author":"Fan","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib401","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/ejhg.2009.94","article-title":"Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study","volume":"17","author":"Ehret","year":"2009","journal-title":"Eur. J. Hum. Genet"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib402","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.113.02191","article-title":"CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney","volume":"63","author":"Rudemiller","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib403","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/HYPERTENSIONAHA.114.04736","article-title":"Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation","volume":"65","author":"Rudemiller","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib404","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41598-022-06452-9","article-title":"Barriers to the donation of living kidneys for kidney transplantation","volume":"12","author":"Min","year":"2022","journal-title":"Sci. Rep."},{"issue":"7982","key":"10.1016\/j.phrs.2026.108104_bib405","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib406","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41587-024-02223-1","article-title":"First gene-edited pig kidney transplant","volume":"42","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib407","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune Responses to Viral Gene Therapy Vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"issue":"4, 2017","key":"10.1016\/j.phrs.2026.108104_bib408","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu. Rev. Virol."},{"issue":"R1","key":"10.1016\/j.phrs.2026.108104_bib409","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib410","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib411","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/mt.2010.258","article-title":"Preclinical Safety Evaluation of AAV2-sFLT01\u2014 A Gene Therapy for Age-related Macular Degeneration","volume":"19","author":"MacLachlan","year":"2011","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib412","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer","volume":"28","author":"Costa Verdera","year":"2020","journal-title":"Mol. Ther."},{"issue":"S1","key":"10.1016\/j.phrs.2026.108104_bib413","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jvh.13919","article-title":"Hepatitis after gene therapy, what are the possible causes?","volume":"31","author":"Maina","year":"2024","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib414","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ymthe.2020.01.006","article-title":"Adenovirus-Antibody Complexes Contributed to Lethal Systemic Inflammation in a Gene Therapy Trial","volume":"28","author":"Somanathan","year":"2020","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib415","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2333729","article-title":"In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies","volume":"16","author":"Mattei","year":"2024","journal-title":"MAbs"},{"issue":"85","key":"10.1016\/j.phrs.2026.108104_bib416","doi-asserted-by":"crossref","DOI":"10.3791\/51308-v","article-title":"A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes","author":"Salvat","year":"2014","journal-title":"JoVE"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib417","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2012.02.012","article-title":"New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes","volume":"379","author":"Quah","year":"2012","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib418","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11095-014-1541-x","article-title":"Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics","volume":"32","author":"Ahmadi","year":"2015","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib419","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178544","article-title":"Quantitative analysis of the CD4+ T-cell response to therapeutic antibodies in healthy donors using a novel T-cell:PBMC assay","volume":"12","author":"Schultz","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib420","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/rme.09.26","article-title":"Engineering Tissue Alternatives to Animals: Applying Tissue Engineering to Basic Research and Safety Testing","volume":"4","author":"Holmes","year":"2009","journal-title":"Regen. Med."},{"key":"10.1016\/j.phrs.2026.108104_bib421","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2013.12.006","article-title":"The use of skin models in drug development","volume":"69-70","author":"Mathes","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2026.108104_bib422","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejpb.2018.06.008","article-title":"In vitro models for immunogenicity prediction of therapeutic proteins","volume":"130","author":"Groell","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib423","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-023-00814-5","article-title":"Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy","volume":"25","author":"Gorovits","year":"2023","journal-title":"AAPS J."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib424","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41434-021-00232-2","article-title":"Cas9-directed immune tolerance in humans\u2014a model to evaluate regulatory T-cells in gene therapy?","volume":"28","author":"Wagner","year":"2021","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib425","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/cmi.2016.39","article-title":"Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches","volume":"14","author":"Diehl","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2026.108104_bib426","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2017.11.006","article-title":"Preclinical models to assess the immunogenicity of AAV vectors","volume":"342","author":"Ertl","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.phrs.2026.108104_bib427","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674021","article-title":"Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning","volume":"12","author":"Wec","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib428","doi-asserted-by":"crossref","first-page":"29","DOI":"10.6026\/973206300200029","article-title":"Artificial intelligence in Immuno-genetics","volume":"20","author":"Farzan","year":"2024","journal-title":"Bioinformation"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib429","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/s41467-024-46017-0","article-title":"A humanized mouse model for adeno-associated viral gene therapy","volume":"15","author":"Barzi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108104_bib430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1011143","article-title":"Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies","volume":"13","author":"Ramamurthy","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib431","first-page":"365","article-title":"Biology-Inspired Microphysiological Systems to Advance Patient Benefit and Animal Welfare in Drug Development","volume":"37","author":"Marx","year":"2020","journal-title":"Altex"},{"key":"10.1016\/j.phrs.2026.108104_bib432","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2025.102422","article-title":"Current regulatory requirements for assessment of immunogenicity for gene therapy medicinal products","author":"Mann","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib433","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1016\/j.ymthe.2024.07.016","article-title":"A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders","volume":"32","author":"Vrellaku","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108104_bib434","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658038","article-title":"Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies","volume":"12","author":"Chu","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib435","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1242\/jcs.003632","article-title":"Processing of recombinant AAV genomes occurs in specific nuclear structures that overlap with foci of DNA-damage-response proteins","volume":"121","author":"Cervelli","year":"2008","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib436","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib437","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.trim.2006.09.018","article-title":"Long-term problems related to immunosuppression","volume":"17","author":"L\u00f3pez","year":"2006","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.phrs.2026.108104_bib438","series-title":"Exploring Novel Clinical Trial Designs for Gene-Based Therapies: Proceedings of a Workshop","article-title":"The National Academies Collection: Reports funded by National Institutes of Health","author":"National Academies of Sciences","year":"2020"},{"issue":"20","key":"10.1016\/j.phrs.2026.108104_bib439","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood.2024024166","article-title":"Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System","volume":"143","author":"Elsallab","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib440","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41591-024-02826-w","article-title":"T-cell lymphoma and secondary primary malignancy risk after commercial CAR T-cell therapy","volume":"30","author":"Ghilardi","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib441","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1038\/s41467-024-47866-5","article-title":"A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID","volume":"15","author":"Cesana","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib442","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib443","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib444","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.phrs.2026.108104_bib445","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMoa2502754","article-title":"Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency","volume":"393","author":"Booth","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib446","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104337","article-title":"Long-term follow-up after authorization of gene therapy: leveraging real-world data","volume":"30","author":"de Haart","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib447","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1523-1755.2002.00164.x","article-title":"Stem cells in the kidney","volume":"61","author":"Al-Awqati","year":"2002","journal-title":"Kidney Int"},{"issue":"6390","key":"10.1016\/j.phrs.2026.108104_bib448","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1126\/science.aar2131","article-title":"Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease","volume":"360","author":"Park","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib449","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.21.5.830","article-title":"Effects of moxalactam and cefotaxime on rabbit renal tissue","volume":"21","author":"Luft","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib450","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1073\/pnas.76.3.1303","article-title":"Presence of heparan sulfate in the glomerular basement membrane","volume":"76","author":"Kanwar","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib451","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1159\/000013543","article-title":"High-resolution ultrastructural comparison of renal glomerular and tubular basement membranes","volume":"19","author":"Ogawa","year":"1999","journal-title":"Am. J. Nephrol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib452","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1097\/01.ASN.0000139478.03463.D9","article-title":"Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria","volume":"15","author":"Lahdenkari","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib453","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40291-020-00467-6","article-title":"Improving Molecular Therapy in the Kidney","volume":"24","author":"Rubin","year":"2020","journal-title":"Mol. Diagn. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib454","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103243","article-title":"Renal subcapsular delivery of PGE(2) promotes kidney repair by activating endogenous Sox9(+) stem cells","volume":"24","author":"Chen","year":"2021","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib455","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1046\/j.1523-1755.2002.0610s1016.x","article-title":"Adenovirus-mediated gene transfer to renal glomeruli in rodents","volume":"61","author":"Ye","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib456","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ki.1994.162","article-title":"Adenoviral-mediated gene transfer to renal tubular cells in vivo","volume":"45","author":"Moullier","year":"1994","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib457","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101333","article-title":"Gene therapy and kidney diseases","volume":"32","author":"Tavakolidakhrabadi","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib458","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.34067\/KID.0000000000000227","article-title":"Animal Models of Kidney Disease: Challenges and Perspectives","volume":"4","author":"Liang","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.phrs.2026.108104_bib459","article-title":"Trends in nephrology: from \u2018translational research\u2019 in animals to research in humans","author":"Podesta","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib460","doi-asserted-by":"crossref","first-page":"F563","DOI":"10.1152\/ajprenal.00402.2023","article-title":"Rodent models of AKI and AKI-CKD transition: an update in 2024","volume":"326","author":"Fu","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.phrs.2026.108104_bib461","first-page":"201","article-title":"On the mechanism of thrombosis","volume":"6","author":"Wessler","year":"1969","journal-title":"Prog. Hematol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib462","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.04120321","article-title":"The Myeloid-Kidney Interface in Health and Disease","volume":"17","author":"Vlasschaert","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib463","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.kint.2020.04.038","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1","volume":"98","author":"Olinger","year":"2020","journal-title":"Kidney Int"},{"issue":"24","key":"10.1016\/j.phrs.2026.108104_bib464","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180347","article-title":"Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors","volume":"134","author":"Bazua-Valenti","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"7544","key":"10.1016\/j.phrs.2026.108104_bib465","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/519410a","article-title":"Don\u2019t edit the human germ line","volume":"519","author":"Lanphier","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib466","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s13238-015-0184-y","article-title":"The moral imperative to continue gene editing research on human embryos","volume":"6","author":"Savulescu","year":"2015","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib467","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1007\/s10943-022-01497-6","article-title":"Playing God? Religious Perspectives on Manipulating the Genome","volume":"61","author":"Kalidasan","year":"2022","journal-title":"J. Relig. Health"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib468","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41591-021-01481-9","article-title":"Gene therapies should be for all","volume":"27","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib469","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101403","article-title":"Ensuring patient access to gene therapies for rare diseases: Navigating reimbursement and coverage challenges","volume":"33","author":"Berry","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2026.108104_bib470","series-title":"Machine Learning in Radiation Oncology: Theory and Applications","first-page":"3","article-title":"What Is Machine Learning?","author":"El Naqa","year":"2015"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib471","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib472","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s10528-024-10799-1","article-title":"Artificial Intelligence and Computational Biology in Gene Therapy: A Review","volume":"63","author":"Danaeifar","year":"2025","journal-title":"Biochem. Genet."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib473","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking drug design in the artificial intelligence era","volume":"19","author":"Schneider","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2026.108104_bib474","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fmedt.2022.1067144","article-title":"Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges","volume":"4","author":"Das","year":"2023","journal-title":"Front. Med. Technol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib475","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4048\/jbc.2023.26.e45","article-title":"Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine","volume":"26","author":"Ahn","year":"2023","journal-title":"J. Breast Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib476","article-title":"From multi-omics data to the cancer druggable gene discovery: a novel machine learning-based approach","volume":"24","author":"Yang","year":"2022","journal-title":"Brief. Bioinforma."},{"key":"10.1016\/j.phrs.2026.108104_bib477","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1109\/RBME.2023.3324264","article-title":"Integrating Multi-Omics Data With EHR for Precision Medicine Using Advanced Artificial Intelligence","volume":"17","author":"Tong","year":"2024","journal-title":"IEEE Rev. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib478","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/bioinformatics\/btu703","article-title":"DANN: a deep learning approach for annotating the pathogenicity of genetic variants","volume":"31","author":"Quang","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.phrs.2026.108104_bib479","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208626","article-title":"Identifying disease genes using machine learning and gene functional similarities, assessed through Gene Ontology","volume":"13","author":"Asif","year":"2018","journal-title":"Plos One"},{"issue":"8","key":"10.1016\/j.phrs.2026.108104_bib480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329640","article-title":"Integrating bioinformatics and machine learning to elucidate the role of protein glycosylation-related genes in the pathogenesis of diabetic kidney disease","volume":"20","author":"Liu","year":"2025","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib481","article-title":"Identification of common biomarkers in diabetic kidney disease and cognitive dysfunction using machine learning algorithms","volume":"14","author":"Peng","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib482","article-title":"Integrating bioinformatics and machine learning to identify glomerular injury genes and predict drug targets in diabetic nephropathy","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib483","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12561-022-09352-8","article-title":"An Artificial Intelligence Approach for Gene Editing Off-Target Quantification: Convolutional Self-attention Neural Network Designs and Considerations","volume":"15","author":"Lin","year":"2023","journal-title":"Stat. Biosci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib484","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41467-021-21337-7","article-title":"PrimeDesign software for rapid and simplified design of prime editing guide RNAs","volume":"12","author":"Hsu","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib485","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf293","article-title":"PrimeNet: rational design of Prime editing pegRNAs by deep learning","volume":"26","author":"Liao","year":"2025","journal-title":"Brief. Bioinforma."},{"issue":"21","key":"10.1016\/j.phrs.2026.108104_bib486","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1016\/j.cell.2025.07.010","article-title":"AI-generated MLH1 small binder improves prime editing efficiency","volume":"188","author":"Park","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib487","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1038\/s41467-025-60495-w","article-title":"Prime editor with rational design and AI-driven optimization for reverse editing window and enhanced fidelity","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib488","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tibs.2024.03.002","article-title":"Computationally guided AAV engineering for enhanced gene delivery","volume":"49","author":"Guo","year":"2024","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib489","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-024-50555-y","article-title":"Systematic multi-trait AAV capsid engineering for efficient gene delivery","volume":"15","author":"Eid","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib490","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","article-title":"Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing","volume":"41","author":"Li","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108104_bib491","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.actbio.2022.09.072","article-title":"Machine learning guided structure function predictions enable in silico nanoparticle screening for polymeric gene delivery","volume":"154","author":"Gong","year":"2022","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib492","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1021\/acs.molpharmaceut.5c00918","article-title":"Pharmacokinetics, Biodistribution, Immunogenicity, and Model-Informed-Based PK\/PD Model of a Next-Generation Advanced Novel Gene Therapy for Hemophilia","volume":"22","author":"Dou","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2026.108104_bib493","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","author":"Witten","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib494","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.metabol.2015.03.005","article-title":"ABCG8 polymorphisms and renal disease in type 2 diabetic patients","volume":"64","author":"Nicolas","year":"2015","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002921","article-title":"New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes","volume":"8","author":"Sandholm","year":"2012","journal-title":"PLOS Genet."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib496","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1681\/ASN.2016020231","article-title":"The Genetic Landscape of Renal Complications in Type 1 Diabetes","volume":"28","author":"Sandholm","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib497","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088273","article-title":"Evaluation of Candidate Nephropathy Susceptibility Genes in a Genome-Wide Association Study of African American Diabetic Kidney Disease","volume":"9","author":"Palmer","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib498","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1681\/ASN.2019030218","article-title":"Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen","volume":"30","author":"Salem","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib499","first-page":"298","article-title":"Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population","volume":"36","author":"Wu","year":"2013","journal-title":"J. Endocrinol. Invest"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002150","article-title":"Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans","volume":"7","author":"Freedman","year":"2011","journal-title":"PLOS Genet."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib501","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/ndt\/gfp316","article-title":"Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD","volume":"24","author":"Freedman","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"issue":"4","key":"10.1016\/j.phrs.2026.108104_bib502","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfr522","article-title":"Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans","volume":"27","author":"Cooke","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib503","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.2337\/diabetes.52.11.2848","article-title":"Association of Solute Carrier Family 12 (Sodium\/Chloride) Member 3 With Diabetic Nephropathy, Identified by Genome-Wide Analyses of Single Nucleotide Polymorphisms","volume":"52","author":"Tanaka","year":"2003","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib504","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1681\/ASN.2012111122","article-title":"Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes","volume":"24","author":"Sandholm","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib505","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1464-5491.2009.02846.x","article-title":"Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes","volume":"26","author":"Craig","year":"2009","journal-title":"Diabet. Med."},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib506","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/dme.12211","article-title":"Investigation of known estimated glomerular filtration rate loci in patients with type 2 diabetes","volume":"30","author":"Deshmukh","year":"2013","journal-title":"Diabet. Med"},{"issue":"6","key":"10.1016\/j.phrs.2026.108104_bib507","doi-asserted-by":"crossref","first-page":"F971","DOI":"10.1152\/ajprenal.00529.2016","article-title":"Knockdown of Add3 impairs the myogenic response of renal afferent arterioles and middle cerebral arteries","volume":"312","author":"Fan","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib508","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41591-018-0194-4","article-title":"Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease","volume":"24","author":"Qiu","year":"2018","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.phrs.2026.108104_bib509","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112878","article-title":"Zinc-finger nuclease knockout of dual-specificity protein phosphatase-5 enhances the myogenic response and autoregulation of cerebral blood flow in FHH.1BN rats","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib510","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.12378","article-title":"Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation","volume":"269","author":"Holmdahl","year":"2016","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib511","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2012.01.003","article-title":"Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension","volume":"15","author":"Feng","year":"2012","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib512","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00631.2017","article-title":"NADPH oxidase 4-derived superoxide mediates flow-stimulated NKCC2 activity in thick ascending limbs","volume":"314","author":"Saez","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib513","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1172\/JCI75079","article-title":"p66Shc regulates renal vascular tone in hypertension-induced nephropathy","volume":"126","author":"Miller","year":"2016","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.phrs.2026.108104_bib514","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1152\/physiolgenomics.00119.2012","article-title":"Heterozygous knockout of transforming growth factor-\u03b21 protects Dahl S rats against high salt-induced renal injury","volume":"45","author":"Chen","year":"2013","journal-title":"Physiol. Genom."},{"issue":"2","key":"10.1016\/j.phrs.2026.108104_bib515","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.2012090927","article-title":"Rab38 Modulates Proteinuria in Model of Hypertension-Associated Renal Disease","volume":"24","author":"Rangel-Filho","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108104_bib516","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"23","key":"10.1016\/j.phrs.2026.108104_bib517","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N. Engl. J. Med"},{"issue":"10","key":"10.1016\/j.phrs.2026.108104_bib518","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat. Genet"},{"issue":"5","key":"10.1016\/j.phrs.2026.108104_bib519","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1681\/ASN.2017080856","article-title":"Characterization of Coding\/Noncoding Variants for SHROOM3 in Patients with CKD","volume":"29","author":"Prokop","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108104_bib520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1101\/gr.182881.114","article-title":"Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity","volume":"25","author":"Yeo","year":"2015","journal-title":"Genome Res"},{"issue":"7","key":"10.1016\/j.phrs.2026.108104_bib521","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001039","article-title":"Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases","volume":"6","author":"Gudbjartsson","year":"2010","journal-title":"PLoS Genet"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:10:47Z","timestamp":1781842247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":521,"alternative-id":["S1043661826000198"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108104","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene modification: Exploring the potential in treating kidney diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108104"}}